CLEANCORE SOLUTIONS INC

Company Overview

CleanCore Solutions, Inc. designs and manufactures aqueous-ozone cleaning systems and complementary sanitation products for janitorial, food service, laundry, ice-machine and industrial customers. The company sells wall-mounted fill stations, portable caddies, laundry and ice-treatment systems and custom industrial units, and supports key verticals including building service management, hospitality, healthcare, education, retail and food processing. Operations are small and concentrated — assembly/manufacturing in Omaha, NE, 15 full-time employees (13 U.S., 2 Ireland), a 15‑patent portfolio (U.S./Canada/Mexico) and increasing international push via an Irish subsidiary and the April 2025 Sanzonate asset acquisition. Fiscal 2025 showed revenue growth (29% to $2.07M) but a materially larger operating loss driven by a $2.53M noncash stock‑based compensation charge, significant G&A increases tied to the NYSE American listing and a disclosed substantial doubt about going concern and near‑term liquidity.

Executive Compensation Practices

Executive pay at CleanCore appears to be heavily equity‑linked: management disclosed large noncash stock‑based compensation (approximately $2.53M in FY2025 and ~$409k in the most recent quarter), which signals use of equity awards to conserve cash and to retain/align executives in a capital‑constrained stage. Given the company’s growth objectives and risks, incentive metrics are likely tied to revenue growth, distributor expansion, gross margin improvement, successful regulatory/field validations (EPA/FIFRA, Health Canada), and milestone achievement for the Sanzonate acquisition/earnouts. The outsized equity component creates meaningful dilution risk to shareholders and can compress reported cash compensation; it may also produce incentives that push for near‑term market value improvements (or milestone attainment) versus longer‑term profitability. The recent rise in D&O insurance and professional fees around the public listing suggests higher governance and compliance costs will continue to be a factor in overall compensation budgeting.

Insider Trading Considerations

Because CleanCore is a very small, thinly traded public company with concentrated customers and limited cash runway, insider transactions often reflect liquidity or financing needs (option exercises, warrant exercises, related‑party loans) as much as executive sentiment about fundamentals. Watch for pattern signals: frequent insider sales following equity or warrant financings can indicate personal liquidity actions rather than loss of confidence, while open‑market purchases by insiders in the context of cash shortfalls can be a stronger positive signal. Regulatory/reporting constraints apply (Form 3/4/5 and Section 16 reporting where applicable), and insiders are likely to use structured plans (10b5‑1) or be subject to blackout windows around earnings, financings, or material acquisition milestones (e.g., Sanzonate earn‑outs). Given the material reliance on regulatory registrations and patents, material developments (EPA/FDA/Health Canada outcomes, patent expirations/defenses, or major customer contract changes) are high‑impact catalysts that can trigger significant insider activity; traders should monitor equity awards, option grants, warrant exercises, related‑party transactions, and disclosure of any hedging/pledging by insiders.